drugset
drugset / Trial / NCT03669172

Efectiveness of Donor IL-15-stimulated NK Cells Post Transplant Infusion in in Acute Leukemia

NCT03669172 ↗

Phase 1/2 Completed 6 enrolled Martín, José Luis Díez, M.D.
NaSingle-groupOpen-labelTreatment

Summary

Clinical trial phase I and II, single-center, historical control, to evaluate the effectiveness of donor IL-15 stimulated NK cells post transplant infusion, in acute leukemia patients with poor prognosis and haploidentical unmanipulated transplant

Timeline

Start
2017-11-02
Primary completion
2021-07-06
Completion
2021-07-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Donor IL-15 stimulated NK cells Cell therapy — —

Indications

acute leukemia